FindTrial
Sign In

A clinical study to see the effect of some ayurvedic formulation in the treatment of vataj shirashoola with reference to tension headache.

A randomized controlled trial to evaluate the efficacy of Mashadi Taila Nasya and Ksheerbala Taila Nasya in management of Vataj Shirashoola with reference to tension headache. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067269
Enrollment
60
Registered
2024-05-14
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G442- Tension-type headache

Interventions

None listed

Sponsors

Sane Guruji Arogya Kendra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patient suffering from symptoms of Vataj Shirashoola irrespective of time period i.e.(Shirso Ruja ,Tivra Nishi Ruja,Shankha Ruja,Lalata Vedna) 2)Patient between age group 19 to 60 yrs. 3)Irrespective of gender , caste and socio-economic status.

Exclusion criteria

Exclusion criteria: 1)Patients who have chronic and systemic illness like hypertension and dibetes. 2)Secondary headache caused by known cases of meningitis, tumor, encephalitis, and refractive errors. 3)Pregnant and lactating women .

Design outcomes

Primary

MeasureTime frame
Symptoms like shankha vedna(temporal pain), Bhru Vedna (pain at eyebrow), Lalata vedna (pain at forehead) , Akshi Vedana(occular pain) will be decreased and relief from tension headache.Timepoint: follow up on 4th, 7th day , symptoms will be noted before and after the treatment—

Secondary

MeasureTime frame
decrease in severity , intensity , duration of symptomsTimepoint: 18 months—

Countries

India

Contacts

Public ContactProf Dr Mrs Nilakshi S Pradhan

MAMS Sumatibhai Shah Ayurved Mahavidyalaya

drnspradhan@yahoo.com9423580963

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026